Treat Your Own Knees: A Self-help Treatment Plan to Fully Rehabilitate 26 Common Knee Injuries and Conditions
Description:
The knee is the most commonly injured joint, and this is the first color book to cover 25 common knee injuries, appealing to a wide cross-section of consumers, from amateur to professional sportspeople. This easy-to-understand book will help a whole range of people, including endurance and team sport athletes and enthusiasts, personal trainers and coaches to understand their knee injury, and show them how to overcome the injury through a proven rehabilitation program. Packed with illustrations of the anatomy of the knee, rehabilitation exercises, plus unique color drawings of each of the 25 knee injuries covered, this will prove an invaluable and indispensible resource.
Best prices to buy, sell, or rent ISBN 9781905367214
Frequently Asked Questions about Treat Your Own Knees: A Self-help Treatment Plan to Fully Rehabilitate 26 Common Knee Injuries and Conditions
The price for the book starts from $8.23 on Amazon and is available from 13 sellers at the moment.
At BookScouter, the prices for the book start at $5.50. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.
If you’re interested in selling back the Treat Your Own Knees: A Self-help Treatment Plan to Fully Rehabilitate 26 Common Knee Injuries and Conditions book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Treat Your Own Knees: A Self-help Treatment Plan to Fully Rehabilitate 26 Common Knee Injuries and Conditions book, the best buyback offer comes from and is $ for the book in good condition.
The Treat Your Own Knees: A Self-help Treatment Plan to Fully Rehabilitate 26 Common Knee Injuries and Conditions book is in very low demand now as the rank for the book is 3,612,164 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.